921 filings
Page 3 of 47
6-K
ATHE
Alterity Therapeutics Ltd
29 Nov 23
Report of Foreign Private Issuer
7:47pm
6-K
ATHE
Alterity Therapeutics Ltd
29 Nov 23
Report of Foreign Private Issuer
6:28am
6-K
ATHE
Alterity Therapeutics Ltd
29 Nov 23
Results of Annual General Meeting
6:23am
6-K
ATHE
Alterity Therapeutics Ltd
29 Nov 23
Report of Foreign Private Issuer
6:17am
6-K
ATHE
Alterity Therapeutics Ltd
29 Nov 23
Not for release to US wire services or distribution in the United States
6:11am
6-K
ATHE
Alterity Therapeutics Ltd
29 Nov 23
Report of Foreign Private Issuer
6:06am
6-K
ATHE
Alterity Therapeutics Ltd
29 Nov 23
Report of Foreign Private Issuer
6:02am
6-K
ATHE
Alterity Therapeutics Ltd
27 Nov 23
Alterity Therapeutics Announces Presentation of Novel Biomarker Data for Evaluation of Multiple System Atrophy
6:42am
6-K
ATHE
Alterity Therapeutics Ltd
22 Nov 23
Report of Foreign Private Issuer
8:04am
6-K
ATHE
Alterity Therapeutics Ltd
22 Nov 23
Report of Foreign Private Issuer
8:02am
6-K
ATHE
Alterity Therapeutics Ltd
22 Nov 23
Report of Foreign Private Issuer
7:59am
6-K
ATHE
Alterity Therapeutics Ltd
22 Nov 23
Report of Foreign Private Issuer
7:57am
6-K
ATHE
Alterity Therapeutics Ltd
22 Nov 23
Report of Foreign Private Issuer
7:20am
6-K
ATHE
Alterity Therapeutics Ltd
20 Nov 23
Report of Foreign Private Issuer
8:00am
6-K
ATHE
Alterity Therapeutics Ltd
15 Nov 23
Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434
9:36pm
6-K
ATHE
Alterity Therapeutics Ltd
7 Nov 23
Alterity Therapeutics Completes Enrolment in ATH434-201 Phase 2 Clinical Trial in Multiple System Atrophy
6:58pm
6-K
ATHE
Alterity Therapeutics Ltd
31 Oct 23
Report of Foreign Private Issuer
6:03am
6-K
ATHE
Alterity Therapeutics Ltd
30 Oct 23
Appendix 4C – Q1 FY24 Quarterly Cash Flow Report
8:00am
EFFECT
ATHE
Alterity Therapeutics Ltd
26 Oct 23
Notice of effectiveness
12:15am
CORRESP
ATHE
Alterity Therapeutics Ltd
23 Oct 23
Correspondence with SEC
12:00am